D.A. Davidson & Co’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Buy
53,019
+3,247
+7% +$672K 0.06% 234
2025
Q4
$10.3M Buy
49,772
+10,462
+27% +$2.09M 0.06% 236
2025
Q3
$7.05M Buy
39,310
+480
+1% +$81.7K 0.05% 284
2025
Q2
$6.26M Sell
38,830
-1,006
-3% -$160K 0.04% 289
2025
Q1
$6.78M Buy
39,836
+2,544
+7% +$442K 0.05% 252
2024
Q4
$6.2M Sell
37,292
-23,047
-38% -$3.94M 0.05% 270
2024
Q3
$10.4M Buy
60,339
+22,829
+61% +$3.78M 0.09% 185
2024
Q2
$5.78M Sell
37,510
-650
-2% -$97.5K 0.05% 266
2024
Q1
$5.87M Sell
38,160
-821
-2% -$125K 0.05% 263
2023
Q4
$6.16M Sell
38,981
-1,794
-4% -$258K 0.06% 240
2023
Q3
$5.97M Sell
40,775
-36,719
-47% -$5.59M 0.06% 237
2023
Q2
$11.9M Sell
77,494
-3,500
-4% -$546K 0.13% 130
2023
Q1
$12.6M Sell
80,994
-37,539
-32% -$5.9M 0.14% 117
2022
Q4
$18.3M Buy
118,533
+3,063
+3% +$452K 0.22% 87
2022
Q3
$15.2M Buy
115,470
+63,872
+124% +$8.96M 0.2% 92
2022
Q2
$7M Buy
51,598
+517
+1% +$71.3K 0.09% 189
2022
Q1
$7.62M Sell
51,081
-2,707
-5% -$400K 0.08% 194
2021
Q4
$8.71M Buy
53,788
+415
+0.8% +$67.1K 0.09% 171
2021
Q3
$8.86M Buy
53,373
+3,932
+8% +$672K 0.1% 157
2021
Q2
$8.54M Buy
49,441
+2,736
+6% +$452K 0.1% 158
2021
Q1
$7.5M Buy
46,705
+1,323
+3% +$227K 0.1% 170
2020
Q4
$7.62M Sell
45,382
-210
-0.5% -$34.1K 0.12% 137
2020
Q3
$7.17M Buy
45,592
+11,036
+32% +$1.8M 0.12% 129
2020
Q2
$5.8M Buy
34,556
+2,086
+6% +$327K 0.11% 137
2020
Q1
$4.26M Buy
32,470
+3,127
+11% +$446K 0.08% 182
2019
Q4
$4.36M Buy
29,343
+1,002
+4% +$138K 0.07% 213
2019
Q3
$3.51M Buy
28,341
+2,908
+11% +$387K 0.06% 239
2019
Q2
$3.58M Sell
25,433
-95
-0.4% -$13.1K 0.07% 224
2019
Q1
$3.85M Buy
25,528
+6,966
+38% +$1M 0.07% 233
2018
Q4
$2.31M Buy
18,562
+3,970
+27% +$543K 0.04% 305
2018
Q3
$2.31M Buy
14,592
+1,500
+11% +$227K 0.04% 325
2018
Q2
$1.83M Buy
13,092
+2,930
+29% +$402K 0.04% 363
2018
Q1
$1.35M Buy
10,162
+4,565
+82% +$623K 0.03% 409
2017
Q4
$697K Buy
5,597
+2,870
+105% +$355K 0.01% 558
2017
Q3
$337K Buy
2,727
+516
+23% +$61.1K 0.01% 803
2017
Q2
$252K Buy
2,211
+1,506
+214% +$162K 0.01% 861
2017
Q1
$74K Sell
705
-255
-27% -$25.6K ﹤0.01% 1360
2016
Q4
$87K Buy
+960
New +$89.9K ﹤0.01% 1356
2016
Q3
Sell
-145
Closed -$12K 2412
2016
Q2
$12K Sell
145
-55
-28% -$5.05K ﹤0.01% 1914
2016
Q1
$17K Sell
200
-10,588
-98% -$933K ﹤0.01% 1757
2015
Q4
$1.22M Sell
10,788
-3,666
-25% -$395K 0.04% 357
2015
Q3
$1.46M Buy
14,454
+872
+6% +$104K 0.05% 320
2015
Q2
$1.68M Buy
13,582
+1,647
+14% +$199K 0.06% 303
2015
Q1
$1.41M Buy
11,935
+677
+6% +$76.5K 0.05% 331
2014
Q4
$1.15M Buy
11,258
+415
+4% +$40.5K 0.04% 377
2014
Q3
$995K Buy
10,843
+458
+4% +$39.7K 0.03% 425
2014
Q2
$854K Sell
10,385
-4,211
-29% -$322K 0.03% 464
2014
Q1
$1.12M Buy
14,596
+1,153
+9% +$90K 0.04% 378
2013
Q4
$929K Buy
13,443
+4,364
+48% +$286K 0.03% 420
2013
Q3
$588K Buy
9,079
+359
+4% +$22.7K 0.03% 464
2013
Q2
$507K Buy
+8,720
New +$498K 0.02% 470

Other funds holding FBT

D.A. Davidson & Co's FBT Position: Q1 2026 in Review

D.A. Davidson & Co increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 6.5% in Q1 2026, buying an estimated $672K and bringing the position to 53,019 shares worth $10.6M. The position accounts for 0.06% of the portfolio, ranked #234.

D.A. Davidson & Co first reported a position in FBT in Q2 2013 and has held it in 51 quarters since. The position peaked at $18.3M in Q4 2022. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • D.A. Davidson & Co held 53,019 shares of First Trust NYSE Arca Biotechnology Index Fund worth $10.6M as of Q1 2026.
  • D.A. Davidson & Co bought 3,247 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $672K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.06% of D.A. Davidson & Co's portfolio in Q1 2026, its #234 holding.
  • D.A. Davidson & Co first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 51 quarters since.
  • D.A. Davidson & Co's First Trust NYSE Arca Biotechnology Index Fund position peaked at $18.3M in Q4 2022.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.